Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-02-19 ROBINS HARLAN S Chief Scientific Officer Sale −3,500 $32.18 $113K 74,579
2020-02-19 ROBINS HARLAN S Chief Scientific Officer Sale −3,900 $33.21 $130K 70,679
2020-02-19 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −7,400 563,000
2020-02-19 RUBINSTEIN JULIE President Option exercise +25,000 $0.84 $21K 25,000
2020-02-19 RUBINSTEIN JULIE President Option exercise +55,000 $0.84 $46K 80,000
2020-02-19 RUBINSTEIN JULIE President Sale −80,000 $33.00 $2.6M 0
2020-02-19 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −25,000 0
2020-02-19 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −55,000 305,000
2020-02-18 ROBINS HARLAN S Chief Scientific Officer Option exercise +18,500 $6.32 $117K 89,179
2020-02-18 ROBINS HARLAN S Chief Scientific Officer Sale −18,500 $31.38 $581K 70,679
2020-02-18 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −18,500 570,400
2020-02-13 GOEL DAVID E. Director Grant or award · Stock Option (Right to Buy) +8,888 8,888
2020-02-13 GRIFFIN MICHELLE RENEE Director Grant or award · Stock Option (Right to Buy) +8,888 8,888
2020-02-13 RUBINSTEIN JULIE President Grant or award · Stock Option (Right to Buy) +200,000 200,000
2020-02-13 LO FRANCIS Chief People Officer Grant or award · Stock Option (Right to Buy) +37,500 37,500
2020-02-13 Cohen Chad M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +85,000 85,000
2020-02-13 ROBINS HARLAN S Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +300,000 300,000
2020-02-13 Pellini Michael J Director Grant or award · Stock Option (Right to Buy) +8,888 8,888
2020-02-13 Taylor Stacy L SVP and General Counsel Grant or award · Stock Option (Right to Buy) +65,000 65,000
2020-02-13 HERSHBERG ROBERT Director Grant or award · Stock Option (Right to Buy) +8,888 8,888

Page 112 of 120 · 2,386 trades